Explore how Sai Parenterals Ltd.’s IPO performed on its first day of subscription, including investor participation, price band details, key dates, and the step-by-step process to apply through ASBA or UPI.
The Sai Parenterals Ltd. IPO opened for subscription on March 24, 2026, marking its debut in the Indian primary market. The company operates in the pharmaceutical segment, focusing on manufacturing and distribution of healthcare products.
The IPO is a book-built issue with a price band of ₹372 to ₹392 per share, aiming to raise approximately ₹408.79 crore. The issue opened with limited initial traction across investor categories.